Delivery Order SPE2DB22D3102-SPE2DB24FL1GM

Award Date 5/23/24
Potential Completion Date 5/24/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,961.25 firm fixed-price delivery order is for the supply of 4566789424 - Duloxetine HCL DR 40 MG capsules, with a completion date of December 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,674.67 firm fixed-price delivery order is for the supply of 4,564,690 units of Duloxetine HCL DR 40 mg capsules. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Duloxetine HCL DR 40 MG capsules. The contract has a firm fixed price of $1,039.68 and a completion date of September 10, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,576.96 under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,566,555,940 units of the medication Duloxetine HCL DR 40 MG capsules. This contract supports the procurement of essential pharmaceutical products and medical supplies for military healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,921.98 firm fixed-price delivery order is for the supply of 4,566,677,517 units of Duloxetine HCL DR 60 mg capsules. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This contract award to Amerisourcebergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4,562,538,971 units of Duloxetine HCL DR 30 MG Capsules, a pharmaceutical product used for various medical treatments. The award has a ceiling value of $1,041.12 and a completion date of October 20, 2023. This contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Duloxetine HCL DR 40 mg capsules. The contract is a delivery order with a firm fixed price of $1,342.68 and an ultimate completion date of December 20, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,756.34 firm fixed price delivery order is for the supply of 4564040998 - Duloxetine HCl DR 40 mg capsules in 30-count packages. This award is under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $14,542.40 firm fixed-price delivery order is for the supply of 4,561,806 units of Duloxetine HCL DR 60 mg capsules. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,460.42, is for the delivery of 4,567,793,444 units of the medication Duloxetine HCL DR 30 MG CAP. The contract is a firm fixed price delivery order with an ultimate completion date of April 4, 2025. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award....
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL1GM
    Delivery Order

This federal contract award, valued at $1,660.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of 4564704255 - Duloxetine HCL DR 40 MG capsules, with a completion date of May 24, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific contract award does not have a set-aside designation, indicating it was competed on a full and open basis.

Generated 8/22/24, 3:51 PM